At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Public ClinicalTrials.gov record NCT01931644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Study identification
- NCT ID
- NCT01931644
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Sanguine Biosciences
- Industry
- Enrollment
- 17,667 participants
Conditions and interventions
Conditions
- ADD/ADHD
- All Diagnosed Health Conditions
- Alopecia Areata
- Ankylosing Spondylitis
- Asthma
- Atopic Dermatitis Eczema
- Beta Thalassemia
- Bipolar Disorder
- Breast Cancer
- Celiac Disease
- Cervical Cancer
- Chronic Inflammatory Demyelinating Polyneuropathy
- Chronic Kidney Diseases
- Chronic Obstructive Pulmonary Disease
- Colon Cancer
- Colorectal Cancer
- Crohn's Disease
- Cystic Fibrosis
- Depression
- Diabetes Mellitus
- Duchenne Muscular Dystrophy
- Endometriosis
- Epilepsy
- Facioscapulohumeral Muscular Dystrophy
- G6PD Deficiency
- General Anxiety Disorder
- HIV/AIDS
- Hepatitis B
- Hereditary Hemorrhagic Telangiectasia
- Human Papilloma Virus
- Huntington's Disease
- Idiopathic Thrombocytopenic Purpura
- Insomnia
- Kidney Cancer
- Leukemia
- Lung Cancer
- Lupus Nephritis
- Lymphoma
- Melanoma
- Multiple Myeloma
- Multiple Sclerosis
- Myositis
- Myotonic Dystrophy
- Ovarian Cancer
- Pancreatic Cancer
- Parkinson's Disease
- Polycystic Kidney Diseases
- Prostate Cancer
- Psoriasis
- Psoriatic Arthritis
- Rosacea
- Scleroderma
- Sickle Cell Anemia
- Sickle Cell Trait
- Sjogren's Syndrome
- Skin Cancer
- Spinal Muscular Atrophy
- Systemic Lupus Erythematosus
- Thrombotic Thrombocytopenic Purpura
- Trisomy 21
- Ulcerative Colitis
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- Mar 31, 2024
- Completion
- Mar 31, 2024
- Last update posted
- Apr 17, 2024
2013 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sanguine Biosciences | Los Angeles | California | 91403 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01931644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01931644 live on ClinicalTrials.gov.